Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial

被引：0
|
作者：
Wolffenbuttel, B. H. R. [1 ]
Nauck, M. A. [2 ]
Shaginian, R.
Malone, J. [3 ]
Cleall, S. [4 ]
de Vries, D.
Hoogwerf, B.
MacConell, L. [5 ]
Diamant, M. [6 ]
机构：
[1] Univ Groningen, NL-9700 AB Groningen, Netherlands
[2] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Eli Lilly & Co, Windlesham, Surrey, England
[5] Bristol Myers Squibb Co, San Diego, CA USA
[6] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 41 条
  • [1] Impact on cardiovascular risk factors of exenatide BID vs insulin lispro TID added to titrated insulin glargine QD in metformin-treated type 2 diabetes mellitus patients: the 4B trial
    Diamant, M.
    Nauck, M. A.
    Shaginian, R.
    Malone, J.
    Cleall, S.
    de Vries, D.
    Hoogwerf, B.
    MacConell, L.
    Wolffenbuttel, B. H. R.
    [J]. DIABETOLOGIA, 2013, 56 : S393 - S394
  • [2] Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less Hypoglycemia: The 4B Study
    Diamant, Michaela
    Nauck, Michael
    Shaginian, Rimma
    Malone, James
    Cleall, Simon
    De Vries, Danielle
    Hoogwerf, Byron J.
    Macconell, Leigh
    Wolffenbuttel, Bruce
    [J]. DIABETES, 2013, 62 : A17 - A18
  • [3] 1.6 Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less Hypoglycemia: The 4B Study (70-OR)
    Michaela Diamant
    Michael Nauck
    Rimma Shaginian
    James Malone
    Simon Cleall
    Daniëlle de Vries
    Byron J. Hoogwerf
    Leigh Macconell
    Bruce Wolffenbuttel
    [J]. Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 79 - 79
  • [4] The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes
    Gordon, J.
    McEwan, P.
    Sabale, U.
    Kartman, B.
    Wolffenbuttel, B. H. R.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (12) : 1167 - 1174
  • [5] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Ting-Ting Yin
    Yan Bi
    Ping Li
    Shan-Mei Shen
    Xiao-Lu Xiong
    Li-Jun Gao
    Can Jiang
    Yan Wang
    Wen-Huan Feng
    Da-Long Zhu
    [J]. Diabetes Therapy, 2018, 9 : 1253 - 1267
  • [6] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Yin, Ting-Ting
    Bi, Yan
    Li, Ping
    Shen, Shan-Mei
    Xiong, Xiao-Lu
    Gao, Li-Jun
    Jiang, Can
    Wang, Yan
    Feng, Wen-Huan
    Zhu, Da-Long
    [J]. DIABETES THERAPY, 2018, 9 (03) : 1253 - 1267
  • [7] Optimizing Glycemic Control in T2DM Patients Previously Treated With Intensive Insulin Therapy and Switched to Exenatide-Insulin Glargine Combination
    Avramidis, Iakovos
    Spyridonidou, Christina
    Stoimenis, Dimitris
    Lalia, Antigoni
    [J]. DIABETES, 2013, 62 : A261 - A261
  • [8] THE COST-EFFECTIVENESS OF EXENATIDE BID VERSUS INSULIN LISPRO TID AS ADD-ON THERAPY TO TITRATED INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES - AN ANALYSIS FROM THE SWEDISH HEALTH CARE PERSPECTIVE
    Gordon, J.
    McEwan, P.
    Sabale, U.
    Kartman, B.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A344 - A344
  • [9] Exenatide achieved equivalent glycaemic control to insulin glargine, with weight reduction and less nocturnal hypoglycaemia, in metformin and sulfonylurea-treated type 2 diabetes
    Heine, RJ
    Van Gaal, LF
    Johns, D
    Mihm, MJ
    Widel, MH
    Brodows, RG
    [J]. DIABETOLOGIA, 2005, 48 : A3 - A3
  • [10] The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial
    Beatriz Gorban de Lapertosa, Silvia
    Frechtel, Gustavo
    Hardy, Elise
    Sauque-Reyna, Leobardo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 122 : 38 - 45
12345